Maci 3CM x 5CM implant sheets
Ended Awarded Last action
- Contract number
- SPE2DB25FAZKT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,539
Award facts
- Contract value 100% obligated
- $61,538.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for MACI 3cm x 5cm implant sheets. The delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply for Department of Defense healthcare operations.
As a regional prime vendor contractor under the PPV-G GEN V framework, DMS Pharmaceutical Group has demonstrated significant federal contracting activity supplying a comprehensive portfolio of pharmaceuticals and medical consumables to military healthcare facilities. The company's established performance across multiple therapeutic categories and specialty surgical products, including MACI implants and other biologics, positions it as a critical supplier within the federal military medical system's pharmaceutical supply chain. The PPV-G GEN V contract extends through December 31, 2036, with a ceiling value of $499,999,999, enabling the Defense Logistics Agency to issue delivery orders such as this one to meet recurring medical supply needs across Department of Defense facilities worldwide.
Quick answers
Who was awarded contract SPE2DB25FAZKT?
SPE2DB25FAZKT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FAZKT worth?
The government has obligated $61,539 on SPE2DB25FAZKT.
Is contract SPE2DB25FAZKT an order under another contract?
Yes. SPE2DB25FAZKT is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZKT competed?
The extent of competition for SPE2DB25FAZKT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award